1. Home
  2. RVP vs BIVI Comparison

RVP vs BIVI Comparison

Compare RVP & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVP
  • BIVI
  • Stock Information
  • Founded
  • RVP 1994
  • BIVI 2013
  • Country
  • RVP United States
  • BIVI United States
  • Employees
  • RVP N/A
  • BIVI N/A
  • Industry
  • RVP Medical/Dental Instruments
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVP Health Care
  • BIVI Health Care
  • Exchange
  • RVP Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • RVP 20.5M
  • BIVI 18.8M
  • IPO Year
  • RVP 2001
  • BIVI N/A
  • Fundamental
  • Price
  • RVP $0.68
  • BIVI $0.76
  • Analyst Decision
  • RVP
  • BIVI Strong Buy
  • Analyst Count
  • RVP 0
  • BIVI 1
  • Target Price
  • RVP N/A
  • BIVI $30.00
  • AVG Volume (30 Days)
  • RVP 29.0K
  • BIVI 244.6K
  • Earning Date
  • RVP 05-14-2025
  • BIVI 05-13-2025
  • Dividend Yield
  • RVP N/A
  • BIVI N/A
  • EPS Growth
  • RVP N/A
  • BIVI N/A
  • EPS
  • RVP N/A
  • BIVI N/A
  • Revenue
  • RVP $33,049,532.00
  • BIVI N/A
  • Revenue This Year
  • RVP N/A
  • BIVI N/A
  • Revenue Next Year
  • RVP N/A
  • BIVI N/A
  • P/E Ratio
  • RVP N/A
  • BIVI N/A
  • Revenue Growth
  • RVP N/A
  • BIVI N/A
  • 52 Week Low
  • RVP $0.56
  • BIVI $0.62
  • 52 Week High
  • RVP $1.22
  • BIVI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • RVP 39.59
  • BIVI 34.74
  • Support Level
  • RVP $0.69
  • BIVI $0.62
  • Resistance Level
  • RVP $0.76
  • BIVI $0.87
  • Average True Range (ATR)
  • RVP 0.06
  • BIVI 0.13
  • MACD
  • RVP -0.00
  • BIVI -0.00
  • Stochastic Oscillator
  • RVP 27.18
  • BIVI 24.09

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: